Biotechnology in Belgium industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.
 
 Scope
 
 * Contains an executive summary and data on value, volume and/or segmentation
 
 * Provides textual analysis of the industry’s recent performance and future prospects
 
 * Incorporates in-depth five forces competitive environment analysis and scorecards
 
 * Includes a five-year forecast of the industry
 
 * The leading companies are profiled with supporting key financial metrics
 
 * Supported by the key macroeconomic and demographic data affecting the market
 
 Highlights
 
 * Detailed information is included on market size, measured by value and/or volume
 
 * Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape
 
 Why you should buy this report
 
 * Spot future trends and developments
 
 * Inform your business decisions
 
 * Add weight to presentations and marketing materials
 
 * Save time carrying out entry-level research
 
 Market Definition
 
 The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2008 annual average exchange rates.
 
 For the purpose of this report Europe is deemed to comprise of Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the Ukraine and the United Kingdom.

EXECUTIVE SUMMARY 3
 CHAPTER 1 Market Overview 7
 1.1 Market Definition 7
 1.2 Research Highlights 7
 1.3 Market Analysis 8
 CHAPTER 2 Market Value 9
 CHAPTER 3 Market Segmentation I 10
 CHAPTER 4 Market Segmentation II 11
 CHAPTER 5 Five Forces Analysis 12
 5.1 Summary 12
 5.2 Buyer Power 13
 5.3 Supplier Power 14
 5.4 New Entrants 15
 5.5 Substitutes 16
 5.6 Rivalry 17
 CHAPTER 6 Leading Companies 18
 6.1 GlaxoSmithKline Plc 18
 6.2 UCB Group 22
 6.3 Amgen Inc. 25
 6.4 Innogenetics N V 27
 CHAPTER 7 Market Forecasts 30
 7.1 Market Value Forecast 30
 CHAPTER 8 Macroeconomic Indicators 31
 CHAPTER 9 Appendix 33
 9.1 Methodology 33
 9.2 Industry Associations 34
 9.3 Related Datamonitor Research 34
 
 LIST OF TABLES
 Table 1: Belgium Biotechnology Market Value: $ billion, 2004-2008 9
 Table 2: Belgium Biotechnology Market Segmentation I: % Share, by Value, 2008 10
 Table 3: Belgium Biotechnology Market Segmentation II: % Share, by Value, 2008 11
 Table 4: Key Facts: GlaxoSmithKline Plc 18
 Table 5: Key Financials: GlaxoSmithKline Plc 21
 Table 6: Key Facts: UCB Group 22
 Table 7: Key Financials: UCB Group 24
 Table 8: Key Facts: Amgen Inc. 25
 Table 9: Key Financials: Amgen Inc. 26
 Table 10: Key Facts: Innogenetics N V 27
 Table 11: Key Financials: Innogenetics N V 29
 Table 12: Belgium Biotechnology Market Value Forecast: $ billion, 2008-2013 30
 Table 13: Belgium Size of Population (million) , 2004-2008 31
 Table 14: Belgium GDP (Constant 2000 Prices, $ billion), 2004-2008 31
 Table 15: Belgium Inflation, 2004-2008 31
 Table 16: Belgium Exchange Rate, 2004-2008 32